Jun 1, 2026 08:32AM
Jun 1, 2026 08:30AM
May 13, 2026 07:30AM
Apr 28, 2026 08:30AM
Apr 28, 2026 08:30AM
Mar 31, 2026 08:30AM
Mar 31, 2026 08:30AM PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
Mar 17, 2026 08:30AM
Mar 17, 2026 08:30AM
Feb 11, 2026 07:31AM
Feb 11, 2026 07:30AM
Dec 3, 2025 08:32AM
Dec 3, 2025 08:30AM
Nov 25, 2025 08:30AM PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
Nov 12, 2025 07:30AM
Nov 6, 2025 08:30AM
Nov 6, 2025 08:30AM
Sep 16, 2025 08:33AM
Sep 16, 2025 08:30AM
Aug 13, 2025 07:30AM
Jun 17, 2025 04:08AM PolyPid Ltd. (PYPD) PT Lowered to $14 at Citizens JMP
Jun 16, 2025 07:20PM
Jun 9, 2025 10:13AM
May 14, 2025 07:00AM
Apr 14, 2025 06:54AM
Dec 26, 2024 06:35AM
Dec 23, 2024 07:22PM
Nov 13, 2024 07:00AM PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Oct 2, 2024 06:47AM
Jun 10, 2024 07:00AM
Aug 9, 2023 07:00AM
Jun 29, 2023 08:00AM
Jun 22, 2023 07:00AM
May 22, 2023 09:01AM
May 22, 2023 09:00AM PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
May 10, 2023 07:00AM
Feb 8, 2023 07:00AM
Jan 24, 2023 07:05AM
Jan 24, 2023 07:00AM
Jan 3, 2023 07:02AM
Jan 3, 2023 07:00AM
Dec 12, 2022 07:06AM PolyPid Ltd. (PYPD) Announces Scheduling of Type D Meeting with U.S. FDA to Discuss SHIELD I Phase 3 Results and Regulatory Pathway for D-PLEX100 for the Prevention of Surgical Site Infections i
Dec 12, 2022 07:00AM
Nov 9, 2022 07:00AM
Oct 20, 2022 07:16AM
Oct 20, 2022 07:09AM
Sep 28, 2022 08:58AM
Sep 28, 2022 08:57AM
Sep 19, 2022 07:01AM PolyPid Ltd. (PYPD) Reports Publication of Phase 2 Clinical Trial Results for D-PLEX
Sep 19, 2022 07:00AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All